Shots: The collaboration is focused on development of Larazotide for Alcoholic Liver Diseases (ALD), including severe alcoholic hepatitis Innovate will conduct an investor update on 17 Dec, 2018 for Larazotide, […]readmore
Tags : (ARGX-110)
Shots: Cilag (subsidiary of Janssen) to get worldwide commercialization rights for Cusatuzumab, with an option for Argenx to take part in the US activities. Argenx to receive $300M upfront, $200M equity […]readmore